David G. Mutch

Nature · 2004–2019

A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from David G. Mutch's perspective

Ordered by how strongly the researchers David G. Mutch trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome (Clinical Cancer Research)
  2. Human protein reference database—2006 update (Nucleic Acids Res.)
  3. An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1 (Cancer Cell)
  4. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma (Proceedings of the National Academy of Sciences of the United States of America)
  5. The landscape of somatic copy-number alteration across human cancers (Nature)
  6. ARID1A mutations in endometriosis-associated ovarian carcinomas. (New England Journal of Medicine)
  7. The Statistical Analysis of Failure Time Data (Technometrics)
  8. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary (Journal of Pathology)
  9. Nonparametric Estimation from Incomplete Observations
  10. The biology of ovarian cancer: new opportunities for translation (Nature Reviews. Cancer)

Their papers